Emerging technologies & innovation systems

A disruptive or path-breaking innovation can deliver remarkable advances in healthcare, agriculture, energy, transport and financial services but innovators in these areas are also faced with great uncertainty around the nature of future business models and value chains. Innogen offers new insights and methodological approaches for foresighting future business models and value chains in the context of an innovation ecosystem that can either support or constrain the eventual market availability of the technology. Innogen’s expertise lies in understanding, assessing and supporting this innovation-led growth.

Projects

Meet Innogen Members: Dr Miguel García-Sancho

23 March 2023

We speak with Dr Miguel García-Sancho, Chancellor’s Fellow and Senior Lecturer at The University of Edinburgh’s School of Social and Political Science, about his forthcoming book and future research plans. His history of science expertise, which sits between the production of scientific knowledge and the broader context in which this knowledge circulates, sheds new light on innovation systems and on how science and technology are used to achieve a range of practical goals.

Innogen research contributes to UK plans for future governance of innovation

1 November 2018

As a member of the UK's Council for Science and Technology, Innogen Institute co-director Joyce Tait was a key contributor to its recent initiative to promote a regulatory landscape that is more proportionate and adaptive to the needs of emerging technologies.

Synbio in the UK – A decade of developments

19 September 2019

The Synthetic Biology Leadership Council (SBLC) has published an overview of UK synbio activities in the last decade.

Meet our Researchers: Prof. Smita Srinivas

21 April 2020

We speak with Prof. Smita Srinivas, Professorial Research Fellow, at The Open University (UK) Founder Director of the Technological Change Lab (TCLab) and Visiting Professor at the National Centre for Biological Sciences (India). Her work focusses on economics and public policy. In 2015 she received the EAEPE (European Association for Evolutionary Political Economy) Joan Robinson Prize for her book on the health industry "Market Menagerie". We discuss her latest paper: Economics and Public Health: a case for interdisciplinary cohesion in the time of Coronavirus and the relevance of her work to the current Covid-19 pandemic.

Rapid diagnostic tests are no panacea for tackling antimicrobial resistance

5 November 2020

Innogen members Ann Bruce and Katie Adam have co-authored a paper as part of the Diagnostic Innovation and Livestock (DIAL) project team, in collaboration with the University of Exeter and Bristol Veterinary School. This new publication explores the potential role of rapid or point-of-care diagnostic tests for farm animals in supporting decisions about antimicrobial use in livestock.